The Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Single-Center Chinese Retrospective Study

References

• Keynan Y, Rubinstein E. The changing face of Klebsiella pneumoniae infections in the community. Int J Antimicrob Agents. 2007;30(5):385–389. doi:10.1016/j.ijantimicag.2007.06.019
   PubMed Web of Science ®Google Scholar
• Singh S, Sharma A, Nag VL. Bacterial pathogens from lower respiratory tract infections: a study from Western Rajasthan. J Family Med Prim Care. 2020;9(3):1407–1412. doi:10.4103/jfmpc.jfmpc_994_19
   PubMedGoogle Scholar
• MacKenzie FM, Forbes KJ, Dorai-John T, Amyes SG, Gould IM. Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet. 1997;350(9080):783. doi:10.1016/S0140-6736(05)62567-6
   Web of Science ®Google Scholar
• Shanthi M, Sekar U, Arunagiri K, Sekar B. Detection of Amp C genes encoding for beta-lactamases in Escherichia coli and Klebsiella pneumoniae. Indian J Med Microbiol. 2012;30(3):290–295. doi:10.4103/0255-0857.99489
   PubMed Web of Science ®Google Scholar
• Sun K, Xu X, Yan J, Zhang L. Evaluation of six phenotypic methods for the detection of carbapenemases in gram-negative bacteria with characterized resistance mechanisms. Ann Lab Med. 2017;37:305–312.
   PubMed Web of Science ®Google Scholar
• Munoz-Price LS, Quinn JP. The spread of Klebsiella pneumoniae carbapenemases: a tale of strains, plasmids, and transposons. Clin Infect Dis. 2009;49:1739–1741. doi:10.1086/648078
   PubMed Web of Science ®Google Scholar
• Orsi GB, García-Fernández A, Giordano A, et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect. 2011;78(1):54–58. doi:10.1016/j.jhin.2011.01.014
   PubMed Web of Science ®Google Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228–236. doi:10.1016/S1473-3099(09)70054-4
   PubMed Web of Science ®Google Scholar
• Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R. Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol. 2009;30:666–671. doi:10.1086/598244
   PubMed Web of Science ®Google Scholar
• Li Y, Lv Y, Xue F, et al. [Antimicrobial susceptibility surveillance of gram-negative bacterial from Mohnarin 2011–2012]. Chin J Clin Pharmacol. 2014;30:260–277. In Chinese.
   Google Scholar
• National Bacterial Resistance Monitoring Network, Expert Committee on Rational Drug Use, National Health and Family Planning Commission. [China Antimicrobial Resistance Surveillance System Report 2014]. China Licensed Pharm. 2016;14:3–8. In Chinese.
   Google Scholar
• Richet HM, Mohammed J, McDonald LC, Jarvis WR. Building communication networks: international network for the study and prevention of emerging antimicrobial resistance. Emerg Infect Dis. 2001;7(2):319–322. doi:10.3201/eid0702.010235
   Web of Science ®Google Scholar
• Akgul F, Bozkurt I, Sunbul M, Esen S, Leblebicioglu H. Risk factors and mortality in the Carbapenem-resistant Klebsiella pneumoniae infection: case control study. Pathog Glob Health. 2016;110(7–8):321–325. doi:10.1080/20477724.2016.1254976
   PubMed Web of Science ®Google Scholar
• Vardakas KZ, Matthaiou DK, Falagas ME, Antypa E, Koteli A, Antoniadou E. Characteristics, risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit. J Infect. 2015;70(6):592–599. doi:10.1016/j.jinf.2014.11.003
   PubMed Web of Science ®Google Scholar
• Jiao Y, Qin Y, Liu J, et al. Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: a retrospective study. Pathog Glob Health. 2015;109:68–74. doi:10.1179/2047773215Y.0000000004
   PubMed Web of Science ®Google Scholar
• Thol F, Ganser A. Treatment of relapsed acute myeloid leukemia. Curr Treat Options Oncol. 2020;21(8):66. doi:10.1007/s11864-020-00765-5
   PubMed Web of Science ®Google Scholar
• Tsakris A, Kristo I, Poulou A, et al. Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. J Clin Microbiol. 2009;47:362–367. doi:10.1128/JCM.01922-08
   PubMed Web of Science ®Google Scholar
• Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol. 2006;44(9):3139–3144. doi:10.1128/JCM.00879-06
   PubMed Web of Science ®Google Scholar
• Gregory CJ, Llata E, Stine N, et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol. 2010;31(05):476–484. doi:10.1086/651670
   Web of Science ®Google Scholar
• Ghebremedhin B. Extended-Spectrum-Betalaktamasen (ESBL): gestern ESBL - heute ESBL, Carbapenemase-Bildner und multiresistente Bakterien [Extended-spectrum of beta-lactamases (ESBL): yesterday ESBL: and today ESBL, carbapenemase-producing and multiresistant bacteria]. Dtsch Med Wochenschr. 2012;137(50):2657–2662. In German. doi:10.1055/s-0032-1327341
   Web of Science ®Google Scholar
• Orsi GB, Bencardino A, Vena A, et al. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case–control study. Infection. 2013;41(1):61–67. doi:10.1007/s15010-012-0354-2
   PubMed Web of Science ®Google Scholar
• Gómez Rueda V, Zuleta Tobón JJ. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study. Colomb Med. 2014;45:54–60. doi:10.25100/cm.v45i2.1417
   PubMed Web of Science ®Google Scholar
• Candevir Ulu A, Kurtaran B, Inal AS, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infection: a serious threat in ICUs. Med Sci Monit. 2015;21:219–224. doi:10.12659/MSM.892516
   PubMed Web of Science ®Google Scholar
• Baquero F, Negri MC, Morosini MI, Blázquez J. Antibiotic-selective environments. Clin Infect Dis. 1998;27(Suppl 1):S5–11. doi:10.1086/514916
   PubMed Web of Science ®Google Scholar
• Sacks D, Baxter B, Campbell BCV, et al.; From the American Association of Neurological Surgeons (AANS), American Society of Neuroradiology (ASNR), Cardiovascular and Interventional Radiology Society of Europe (CIRSE), Canadian Interventional Radiology Association (CIRA), Congress of Neurological Surgeons (CNS), European Society of Minimally Invasive Neurological Therapy (ESMINT), European Society of Neuroradiology (ESNR), European Stroke Organization (ESO), Society for Cardiovascular Angiography and Interventions (SCAI), Society of Interventional Radiology (SIR), Society of NeuroInterventional Surgery (SNIS), and World Stroke Organization (WSO). Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke. 2018;13(6):612–632. doi:10.1177/1747493018778713.
   PubMed Web of Science ®Google Scholar